Clarivate PLC – Recent Corporate Actions and Upcoming Earnings Report
Clarivate PLC (NYSE: CLVT)
- Sector: Industrials
- Primary Exchange: New York Stock Exchange
- Currency: USD
- Market Capitalisation: 1 230 000 000 USD
- Recent Close Price (2026‑09‑21): 1.89 USD
- 52‑Week High (2025‑10‑02): 3.96 USD
- 52‑Week Low (2026‑02‑22): 1.66 USD
1. Pricing Terms of Offer to Purchase Outstanding Debt Securities
On 23 September 2026, Clarivate PLC announced that its wholly‑owned subsidiary, Clarivate Science Holdings Corporation, had issued an Offer to Purchase for certain outstanding debt securities. The Offer, dated 17 September 2026, includes the following key elements:
| Item | Detail |
|---|---|
| Reference Yield | As specified in the offer document (exact figure not disclosed in the release). |
| Total Consideration | As specified in the offer document (exact figure not disclosed in the release). |
| Offeror | Clarivate Science Holdings Corporation (subsidiary of Clarivate PLC). |
| Subject to Conditions | The offer is contingent upon conditions set forth in the Offer to Purchase. |
The announcement was made via a press release on www.finanznachrichten.de and identified Clarivate as a leading global provider of transformative intelligence.
2. Upcoming Third‑Quarter 2026 Results
On 22 September 2026, Clarivate PLC confirmed that it will release its financial results for the third quarter of 2026 on 3 November 2026. The key points of the announcement are:
- Release Timing: Results will be available before the market opens on Tuesday, 3 November 2026.
- Information Sources:
- Press release and earnings supplement will be posted on the Clarivate investor website (https://ir.clarivate.com ).
- A conference call and webcast will be hosted at 8:30 AM Eastern Time on the same day.
- The webcast is open to all interested parties and may contain forward‑looking information.
The announcement was simultaneously distributed through www.finanznachrichten.de and www.prnewswire.com , reinforcing the company’s commitment to transparent communication with investors and the broader market.
3. Contextual Overview
Clarivate PLC’s financial position is characterised by a negative price‑earnings ratio of ‑3.78, indicating that the company is operating at a loss relative to its stock price. Despite this, the company maintains a sizeable market capitalisation of over 1.2 billion USD and operates from its base in London, UK, while being listed on the New York Stock Exchange. The company’s product suite spans scientific and academic research, biopharma, medtech, intellectual property intelligence, consultation, and data services.
The recent debt‑purchase offer and the forthcoming earnings report represent key events that will likely influence investor perception and the company’s capital structure. Investors should monitor the detailed terms of the debt offer and the Q3 financial results to assess Clarivate’s ongoing strategic and financial trajectory.
